RealNose.ai is building a machine-olfaction platform that digitizes scent. Its chips use stabilized mammalian olfactory receptors that respond to airborne molecules, and its reader converts the response pattern into an electronic signal that software learns to match to defined targets. The company is initially targeting prostate cancer detection from urine and defense chemical sensing.
A machine-olfaction platform that digitizes scent using stabilized mammalian olfactory receptors on a chip. The reader records the response pattern across receptors, and software learns which patterns match a defined target, enabling field-ready chemical sensing for defense and other applications.
Click to read more
An in-development urine-based assay for prostate cancer detection that aims to help clinicians decide on biopsies after elevated PSA results. It is intended to be run as a single-lab test; clinical performance still requires prospective validation.
Click to read more